Open access
100
Views
10
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
Henry Covelli1 Kootenai Health, Coeur d’Alene, ID, USACorrespondence[email protected]
, Bonavuth Pek2 Clinique de Pneumologie et de Sommeil de Lanaudière, Quebec, Canada
, Isabelle Schenkenberger3 Klinische Forschung, Berlin, Germany
, Catherine Scott-Wilson4 GlaxoSmithKline Inc., Research Triangle Park, Durham, NC, USA
, Amanda Emmett5 PAREXEL International, Durham, NC, USA
& Courtney Crim4 GlaxoSmithKline Inc., Research Triangle Park, Durham, NC, USA
Pages 1-12
|
Published online: 18 Dec 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.